Last updated at 16 Aug 2024 10:01 PM
Director
DIN: 06491743
Sai Sevella Bhavani is currently associated with 2 companies as Director. They serve as a Director at CREDENCE FORMULATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06491743.Sai Sevella Bhavani has previously been associated with 2 companies in roles such as Director and Additional Director.Sai Sevella Bhavani is currently involved in 1 different role. Their most recent position is with REGINA MEDICORP PRIVATE LIMITED as a Director. The first company Sai Sevella Bhavani was appointed to as a director was CREDENCE FORMULATIONS PRIVATE LIMITED. Sai Sevella Bhavani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sai Sevella Bhavani is currently associated with 2 companies as Director. They serve as a Director at CREDENCE FORMULATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 06491743.Sai Sevella Bhavani has previously been associated with 2 companies in roles such as Director and Additional Director.Sai Sevella Bhavani is currently involved in 1 different role. Their most recent position is with REGINA MEDICORP PRIVATE LIMITED as a Director. The first company Sai Sevella Bhavani was appointed to as a director was CREDENCE FORMULATIONS PRIVATE LIMITED. Sai Sevella Bhavani is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
2
Female
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (0)
Past Companies (2)
2y 7m 1y 4m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| CREDENCE FORMULATIONS PRIVATE LIMITED | Director | 15-Sep-2018 |
| REGINA MEDICORP PRIVATE LIMITED | Director | 30-Sep-2019 |